Centralized CRC Screening Outreach Intervention Improves Screening Rates
.jpeg?width=1200)
WEDNESDAY, Dec. 4, 2024 -- A centralized colorectal cancer (CRC) screening outreach intervention involving mailed fecal immunochemical tests (FITs) is effective for increasing screening completion and detection of advanced colorectal neoplasia, according to a study published online Nov. 25 in JAMA Network Open.
Daniel S. Reuland, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues examined the effectiveness of a centralized CRC screening outreach intervention involving mailed FIT outreach and patient navigation to colonoscopy after abnormal FIT results. Patients were enrolled and randomly assigned to usual care alone (control group) or intervention (2,001 participants per group). Intervention participants received mailed screening outreach materials including an introductory letter, FIT kit packet with instructions and return postage, and two reminder letters if necessary, in addition to usual care. Navigation to facilitate follow-up colonoscopy was offered to intervention participants with positive results of mailed FIT.
The researchers found that intervention participants were more likely than controls to complete screening within six months of randomization (30.0 versus 9.7 percent). The intervention was found to be effective in all insurance types. Overall, 68.8 percent of the 48 participants with positive FIT results in the intervention arm completed follow-up colonoscopy within six months compared with 44.4 percent of 18 participants in the control arm. Advanced colorectal neoplasia was detected in 1.4 and 0.7 percent of intervention and control participants, respectively.
"We found that a centralized mailed FIT outreach intervention and patient navigation effectively increased CRC screening among diverse populations served by independent federally qualified health centers," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.